Asset Details
Do you wish to reserve the book?
Low-frequency bladder vibration for the treatment of urinary tract infections in spinal cord injury patients with neurogenic bladder
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Low-frequency bladder vibration for the treatment of urinary tract infections in spinal cord injury patients with neurogenic bladder
Do you wish to request the book?
Low-frequency bladder vibration for the treatment of urinary tract infections in spinal cord injury patients with neurogenic bladder
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Low-frequency bladder vibration for the treatment of urinary tract infections in spinal cord injury patients with neurogenic bladder
2025
Overview
Purpose
Evaluate if low-frequency bladder vibration (LFBV) combined with clean intermittent catheterization (CIC) alleviated urinary tract infections (UTIs) in spinal cord injury (SCI) patients with neurogenic bladder (NB).
Methods
A single-blind randomized controlled trial was conducted. Patients who developed UTIs while rehabilitating from SCI were enrolled continuously between January 2021 and March 2023 and randomly assigned to the control or the intervention group. Patients in the intervention group received LFBV twice daily (5–10 Hz, 5–10 min each time) for 10 days. The primary endpoint was urinary leucocytes, and various other UTI indexes were also tracked. The follow-up lasted four weeks.
Results
The control group (n = 44) and the intervention group (n = 43) were indistinguishable in the basic patient characteristics. Compared to the control group, the intervention group has significantly higher urinary leucocytes on day 2 and significantly lower urinary leucocytes and urinary bacteria on day 10. Four weeks after LFBV, the intervention group had significantly lower urinary leucocytes and post-void residual volume, fewer signs and symptoms of urinary tract infection, as well as significantly higher urine volume. There was no significant change in urinary red blood cells or occult blood due to LFBV.
Conclusion
Applying LFBV to SCI/NB patients with UTIs is recommended.
Publisher
Springer Netherlands,Springer Nature B.V
Subject
